Autism is a developmental difference, not an injury that 'recovers'. Infusions do not reverse a diagnosis or change typical development. Children keep growing regardless; any perceived improvement may reflect natural maturation or concurrent behavioural therapy. Clinics sometimes describe a 2–4 week 'adjustment'; meaningful assessment should occur over months. Expect minimal disruption to routine and no sudden transformations.
Twenty-six registered trials and 6 actively recruiting studies explore stem-cell approaches in autism, primarily small, uncontrolled observational designs. Published reports describe behavioural changes in individual cases, but lack placebo controls, randomisation, or blinded assessment. Most data come from Asia-Pacific clinics; few reach peer-reviewed journals. The theoretical rationale — that placental MSCs reduce neuroinflammation — remains unproven in human brains. No trial has demonstrated meaningful, durable change in core autism features attributable to stem cells alone.
Am I a candidate? → · Autism Spectrum Disorder: full overview → · Autism Spectrum Disorder cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
Medicina regenerativa certificada GMP en el corazón de la UE — desde 3.000–8.000 €, una fracción de los precios de EE. UU. o Alemania. Protocolos personalizados para pacientes de más de 50 países.
Evaluación médica gratuita